Enhanced clearance of HIV-1-infected cells by broadly neutralizing antibodies against HIV-1 in vivo
Anti-retroviral drugs and antibodies limit HIV-1 infection by interfering with the viral life-cycle. In addition, antibodies also have the potential to guide host immune effector cells to kill HIV-1 infected cells. Examination of the kinetics of HIV-1 suppression in infected individuals by passively...
Main Authors: | Lu, C.-L., Bournazos, S., Schoofs, T., Halper-Stromberg, A., Horwitz, J. A., Nogueira, L., Golijanin, J., Gazumyan, A., Ravetch, J. V., Caskey, M., Nussenzweig, M. C., Murakowski, Dariusz Krzysztof, Chakraborty, Arup K, Sarkar, Debolina |
---|---|
Other Authors: | Institute for Medical Engineering and Science |
Format: | Article |
Language: | en_US |
Published: |
American Association for the Advancement of Science (AAAS)
2017
|
Online Access: | http://hdl.handle.net/1721.1/106889 https://orcid.org/0000-0002-9920-4980 https://orcid.org/0000-0003-1268-9602 |
Similar Items
-
Modelling and in vitro testing of the HIV-1 Nef fitness landscape
by: Barton, John P, et al.
Published: (2021) -
Paired quantitative and qualitative assessment of the replication-competent HIV-1 reservoir and comparison with integrated proviral DNA
by: Lorenzi, Julio C. C., et al.
Published: (2018) -
Characterization of anti-HIV-1 neutralizing and binding antibodies in chronic HIV-1 subtype C infection
by: Archary, Derseree, et al.
Published: (2014) -
Toxoplasmosis in HIV and non HIV prisoners in Malaysia
by: Angal, L., et al.
Published: (2016) -
Adenovirus-vectored vaccine containing multidimensionally conserved parts of the HIV proteome is immunogenic in rhesus macaques
by: Murakowski, Dariusz K, et al.
Published: (2021)